Injection manufacturing and pharmaceutical formulations in India.
Annual revenue $4.4M Latest available
Total funding - Funding intelligence
Employees 30 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Systochem

Systochem is a company based in Delhi (India). The company has 30 employees as of April 02, 2024. Systochem offers products and services including Injections and Ophthalmic Eye/Ear Drops.

  • Headquarter Delhi, India
  • Employees 30 as on 02 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Systochem Laboratories Ltd
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.36 M (USD)
    47.88
    as on Mar 31, 2022
  • Net Profit
    $97.58 K (USD)
    72.33
    as on Mar 31, 2022
  • EBITDA
    $271.09 K (USD)
    15.37
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    30

    as on Apr 02, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Systochem

Systochem offers a comprehensive portfolio of products and services, including Injections and Ophthalmic Eye/Ear Drops.

Product name locked
Category locked
Primary

Injections are produced for intravenous, intramuscular, and subcutaneous administration to ensure effective drug delivery

Product name locked
Category locked
Locked

Ophthalmic eye/ear drops are manufactured as part of a broader range of formulations for targeted treatments

Funding Insights of Systochem

Premium access

Detailed funding history for Systochem

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Systochem

Investments
Premium access

Investment portfolio details for Systochem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Systochem

Premium access

Detailed financials for Systochem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Systochem Comparisons

Systochem Primary company
Description
Injection manufacturing and pharmaceutical formulations in I...
Location
Delhi, India
Founded Year
-
Annual Revenue
$4.36 M (USD)
Net Profit
$97.58 K (USD)
EBITDA
$271.09 K (USD)
Employees
30
As of 2024
Premium access

Peer comparison for Systochem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Systochem

Premium access

Detailed competitors of Systochem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Systochem

Premium access

Complete news archive for Systochem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Systochem

Systochem is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

As of Apr 02, 2024, the latest employee count at Systochem is 30.

Annual revenue of Systochem is $4.36M as on Mar 31, 2022.

Systochem Laboratories Ltd. is involved in the manufacturing of injections and other pharmaceutical products, with a focus on research and development of formulations such as injections, capsules, tablets, syrups, and eye and ear drops. Injections for intravenous, intramuscular, and subcutaneous use are produced to offer rapid action and high bioavailability, particularly for drugs that are not effective orally. Quality is maintained through vigilant oversight of production, storage, and quality control processes to meet international standards. The companys efforts are directed towards advancing healthcare through these offerings, ensuring processes are conducted with a commitment to cleanliness and efficiency in facilities located in Delhi and Loni, India.

Systochem offers Injections and Ophthalmic Eye/Ear Drops.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available